Core Viewpoint - Reliance Global Group, Inc. has declared a special cash dividend of $0.03 per common share, reflecting the company's commitment to rewarding shareholders while executing its growth strategy [1][2]. Financial Performance - The company has made significant progress in strengthening its financial performance and balance sheet over the past several quarters [2]. - The dividend payment is scheduled for December 2, 2025, to stockholders of record as of October 30, 2025 [1][4]. Shareholder Value - The special dividend is intended to deliver near-term value to shareholders, demonstrating the company's confidence in the sustainability of its business model [2]. - The disciplined approach to capital allocation includes a recently announced strategy for investing in digital assets, specifically Ethereum and Cardano, aimed at enhancing long-term treasury management and overall shareholder value [2]. Growth Strategy - The company remains focused on driving long-term growth through its Insurtech platform and agency network [2][4]. - Future capital allocation strategies, including potential dividends or other returns of capital, will be at the discretion of the Board [4].

Core Viewpoint - LIXTE Biotechnology Holdings, Inc. is diversifying its treasury by purchasing cryptocurrencies, specifically 10.5 Bitcoin and 300 Ethereum, totaling approximately $2.6 million, which now constitutes about 43.6% of its treasury holdings [2][3]. Group 1: Cryptocurrency Strategy - The company has received approval from its Board of Directors to increase its cryptocurrency allocation to up to 50% of its treasury [2]. - The addition of Bitcoin and Ethereum is part of a strategy to build a balanced digital asset portfolio that complements cash holdings [3]. - The company aims to enhance its adaptability and long-term growth in the digital economy through this diversification [3]. Group 2: Company Overview - LIXTE is a clinical-stage pharmaceutical company focused on developing new cancer therapies, particularly its lead compound, LB-100, which has shown promise in enhancing chemotherapy and immunotherapy outcomes [4][5]. - The company is engaged in pioneering research in cancer biology, specifically in the area of activation lethality, and is currently conducting proof-of-concept clinical trials for various cancer types [5].

Core Viewpoint - Reborn Coffee Inc. is piloting a digital asset ATM in Southern California to explore customer access to cryptocurrencies and stablecoins, aiming to enhance the in-store experience and evaluate customer interest [1][2][3]. Group 1: Digital Asset Strategy - The digital asset ATM will support transactions in Bitcoin and select U.S. dollar-pegged stablecoins like USD Coin (USDC) [1]. - The ATM will be operated by a licensed third-party provider, allowing customers to buy or sell supported digital assets during regular store hours [2]. - The pilot program is part of a measured approach to integrating digital asset capabilities into operations, focusing on compliance and customer engagement [3]. Group 2: Pilot Program Details - The pilot will be limited to one high-traffic location and will run for a defined evaluation period, with the company reviewing usage data and customer feedback [3]. - This initiative follows previous announcements regarding the company's digital asset strategy and planned crypto payment capabilities via Square POS [4]. Group 3: Company Overview - Reborn Coffee, Inc. is a specialty coffee retailer based in California, dedicated to delivering high-quality coffee experiences and redefining the coffeehouse model through innovation [6].

Core Viewpoint - Bit Origin Ltd has successfully closed a private placement for 20 million Class A ordinary shares, raising a total of 30 million DOGE, aimed at enhancing its Dogecoin treasury [1][2]. Group 1: Private Placement Details - The private placement was executed at an acquisition cost of $0.2 per DOGE, which aligns with the company's strategy to scale its DOGE holdings [1][2]. - This initiative is part of a broader plan that includes a previously announced $500 million equity purchase and convertible note facility, positioning Bit Origin to build one of the largest Dogecoin treasuries among publicly traded companies [2]. Group 2: Financial Metrics - As of August 11, 2025, Bit Origin holds 70,543,745 DOGE, with an average acquisition cost of approximately $0.2268 per DOGE [7]. - The Pro Forma DOGE-Per-Share (DPS) is estimated to be around 0.80, calculated by dividing the company's current DOGE holdings by the total number of Class A and Class B ordinary shares outstanding [3][7].